基本信息
浏览量:124
职业迁徙
个人简介
CESAR V. BORLONGAN, Ph.D. is a world leader in stem cell therapy for stroke. His translational bench to clinic research has led to 6 FDA-approved clinical trials of cell transplantation, including the world's first cell therapy in stroke patients. He is an author of 500 peer-reviewed publications, lead editor of 2 books, and serves as editor of solid scientific journals, including Stem Cells, Stroke, JCBFM, Translational Stroke Research, FASEB J, Scientific Reports, Brain Research, and PLoS One. He is a regular study section member of NIH, VA, DOD,and AHA, chairs the State of Maryland Stem Cell Research Funds. He is AAAS and AIMBE Fellow, previous President of ASNTR, and current President of IPLASS. He was featured in The Lancet Neurology “Lifeline” 2008.
研究兴趣
论文共 775 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
PubMedno. 3 (2024)
Journal of cerebral blood flow and metabolism (2024)
Journal of Biomedical Scienceno. 1 (2024): 1-24
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISMpp.271678X241227022-271678X241227022, (2024)
Neural regeneration researchno. 10 (2024): 2111-2112
Cellsno. 5 (2024): 435-435
STEM CELLS TRANSLATIONAL MEDICINEno. 2 (2024): 177-190
ENEUROno. 7 (2024)
加载更多
作者统计
#Papers: 775
#Citation: 25945
H-Index: 81
G-Index: 132
Sociability: 8
Diversity: 0
Activity: 4
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn